Operator: Greetings and welcome to the Matinas BioPharma First Quarter 2023 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Matinas BioPharma (NYSE:MTNB) CEO & Co-founder Jerry Jabbour joins Natalie Stoberman from the Proactive newsroom to discuss the company s latest growth and.
Operator: Greetings and welcome to the Matinas BioPharma 2022 Fourth Quarter and Full Year Conference Call. As a reminder, this conference is being recorded.
Pulling the trigger on new investments becomes exponentially harder when surprises keep popping up, but uncertain ground is also fertile soil for opportunities.